SCHEMBL4961872

SCHEMBL4961872

O=C([C@H]1CCCNC1)N(c1ccc(Oc2ccccc2)cc1)C1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 6/20 0.46
▸ SLC6A4 P31645 6/20 0.46
▸ KCNH2 Q12809 5/20 0.46
▸ CYP2D6 P10635 3/20 0.46
▸ SLC6A3 Q01959 3/20 0.46
▸ TRPM8 Q7Z2W7 3/20 0.43
▸ CHRM2 P08172 2/20 0.43
▸ CHRM3 P20309 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ MITF O75030 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ PAX8 Q06710 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ CDK9 P50750 1/20 0.39
▸ MAPT P10636 2/20 0.39
▸ LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4962814 0.89 CHRM2 (0.52) SLC6A2SLC6A4KCNH2CYP2D6SLC6A3
SCHEMBL4963040 0.89 CHRM2 (0.52) SLC6A2SLC6A4KCNH2CYP2D6SLC6A3
SCHEMBL4960293 0.86 TRPM8 (0.50) KCNH2TRPM8ALDH1A1NPC1RAB9A
SCHEMBL4961292 0.81 CHRM2 (0.48) SLC6A2SLC6A4KCNH2CYP2D6SLC6A3
SCHEMBL4961245 0.80 MLYCD (0.41) SLC6A2SLC6A4KCNH2CYP2D6SLC6A3
SCHEMBL4960546 0.80 MTNR1A (0.44) TRPM8NPC1RAB9ACDK9
SCHEMBL4962417 0.79 GPR88 (0.45) SLC6A2SLC6A4KCNH2CYP2D6SLC6A3
SCHEMBL4962482 0.79 F10 (0.46) KCNH2CHRM2CHRM3KDM4ENPC1
SCHEMBL4962534 0.79 CHRM2 (0.46) SLC6A2SLC6A4KCNH2CYP2D6SLC6A3
SCHEMBL4962731 0.76 TRPM8 (0.41) SLC6A2SLC6A4KCNH2SLC6A3TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758580-A4 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORP (US) 2008-01-16 — — EP claimed
EP-1758580-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS Incyte Corporation (US) 2007-03-07 — — EP claimed
WO-2006012226-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2006-02-02 — — WO claimed
EP-1758580-A4 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORP (US) 2008-01-16 — — EP disclosed
EP-1758580-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS Incyte Corporation (US) 2007-03-07 — — EP disclosed
WO-2006012226-A2 N-SUBSTITUTED PIPERIDINES AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2006-02-02 — — WO disclosed
Send feedback